Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures | ||||
U.S. Dollars in thousands, except per share amounts | ||||
| ||||
| Three months ended | Year ended | ||
| December 31 | December | ||
| 2019 | 2018 | 2019 | 2018 |
| Unaudited | |||
|
|
|
|
|
GAAP net income | $3,062 | $2,303 | $28 | $574 |
Equity-based compensation expense included in cost of revenue | 166 | 108 | 630 | 588 |
Equity-based compensation expense included in research and development expenses | 1,543 | 1,267 | 5,857 | 5,141 |
Equity-based compensation expense included in sales and marketing expenses | 383 | 341 | 1,495 | 1,587 |
Equity-based compensation expense included in general and administrative expenses | 779 | 568 | 2,736 | 3,051 |
Income tax benefit related to equity-based compensation expenses | (101) | (312) | (574) | (712) |
Amortization of intangible assets related to acquisitions of RivieraWaves and Hillcrest Labs business, investments in NB-IoT and Immervision technologies, and deal costs and write off of an acquired lease related the Hillcrest Labs transaction | 945 | 304 | 3,203 | 1,241 |
Revaluation of investment in other company, net of taxes | — | 670 | — | 670 |
Non-GAAP net income | $6,777 | $5,249 | $13,375 | $12,140 |
|
|
|
|
|
GAAP weighted-average number of Common Stock used in computation of diluted net income per share (in thousands) | 22,373 | 22,197 | 22,323 | 22,503 |
Weighted-average number of shares related to outstanding stock-based awards (in thousands) | 462 | 404 | 475 | 388 |
Weighted-average number of Common Stock used in computation of diluted earnings per share, excluding the above (in thousands ) | 22,835 | 22,601 | 22,798 | 22,891 |
|
|
|
|
|
GAAP diluted net income per share | $0.14 | $0.10 | $0.00 | $0.03 |
Equity-based compensation expense, net of taxes | $0.12 | $0.09 | $0.45 | $0.42 |
Amortization of intangible assets related to acquisitions of RivieraWaves and Hillcrest Labs business, investments in NB-IoT and Immervision technologies, and deal costs and write off of an acquired lease related the Hillcrest Labs transaction | $0.04 | $0.01 | $0.14 | $0.05 |
Revaluation of investment in other company, net of taxes | — | $0.03 | — | $0.03 |
|
|
|
|
|
Non-GAAP diluted net income per share | $0.30 | $0.23 | $0.59 | $0.53 |
|
|
|
|
|
CEVA, Inc. Announces Fourth Quarter and Year End 2019 Financial Results
| | More IC News |
|
RELATED NEWS